company background image
300832 logo

Shenzhen New Industries Biomedical Engineering SZSE:300832 Stock Report

Last Price

CN¥68.40

Market Cap

CN¥54.3b

7D

6.2%

1Y

19.6%

Updated

25 Apr, 2024

Data

Company Financials +

Shenzhen New Industries Biomedical Engineering Co., Ltd.

SZSE:300832 Stock Report

Market Cap: CN¥54.3b

300832 Stock Overview

Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally.

300832 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Shenzhen New Industries Biomedical Engineering Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenzhen New Industries Biomedical Engineering
Historical stock prices
Current Share PriceCN¥68.40
52 Week HighCN¥83.50
52 Week LowCN¥49.86
Beta-0.61
1 Month Change-10.26%
3 Month Change-5.13%
1 Year Change19.58%
3 Year Change-4.44%
5 Year Changen/a
Change since IPO187.52%

Recent News & Updates

Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

Apr 09
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Mar 18
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Recent updates

Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

Apr 09
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Mar 18
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Mar 01
Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Shareholder Returns

300832CN Medical EquipmentCN Market
7D6.2%4.0%-0.4%
1Y19.6%-16.8%-14.4%

Return vs Industry: 300832 exceeded the CN Medical Equipment industry which returned -16.8% over the past year.

Return vs Market: 300832 exceeded the CN Market which returned -14.4% over the past year.

Price Volatility

Is 300832's price volatile compared to industry and market?
300832 volatility
300832 Average Weekly Movement5.5%
Medical Equipment Industry Average Movement7.9%
Market Average Movement8.8%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 300832 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300832's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19952,627Rao Weiwww.snibe.com

Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. It offers immunoassay, biochemistry/electrolyte, molecular diagnostics, point of care testing, lab automation, and integrated system, products. The company was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.

Shenzhen New Industries Biomedical Engineering Co., Ltd. Fundamentals Summary

How do Shenzhen New Industries Biomedical Engineering's earnings and revenue compare to its market cap?
300832 fundamental statistics
Market capCN¥54.33b
Earnings (TTM)CN¥1.65b
Revenue (TTM)CN¥3.93b

32.5x

P/E Ratio

13.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300832 income statement (TTM)
RevenueCN¥3.93b
Cost of RevenueCN¥1.06b
Gross ProfitCN¥2.87b
Other ExpensesCN¥1.21b
EarningsCN¥1.65b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)2.10
Gross Margin72.96%
Net Profit Margin42.08%
Debt/Equity Ratio0%

How did 300832 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

47%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.